BEROTRALSTAT HYDROCHLORIDE

BEROTRALSTAT HYDROCHLORIDE was reported 911 times

BEROTRALSTAT HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 UNADJUSTED DOSE ADMINISTERED 6 0.0882
1 ADMINISTRATION SITE MASS 1 0.0357
2 HEREDITARY ANGIOEDEMA 258 0.0240
3 OLFACTORY DYSFUNCTION 1 0.0238
4 PROSTATE TENDERNESS 1 0.0189
5 LIMB PROSTHESIS USER 1 0.0185
6 VACCINATION SITE SWELLING 3 0.0174
7 CAROTIDYNIA 1 0.0172
8 IMPERCEPTION 1 0.0141
9 DRUG TITRATION 2 0.0128
10 OVERWORK 1 0.0128
11 ADMINISTRATION SITE OEDEMA 1 0.0116
12 ERYTHEMA ANNULARE 3 0.0103
13 OPTIC DISC OEDEMA 1 0.0086
14 VACCINATION SITE REACTION 1 0.0078
15 LOSS OF DREAMING 1 0.0075
16 CEREBROVASCULAR STENOSIS 1 0.0068
17 SCAN MYOCARDIAL PERFUSION ABNORMAL 1 0.0065
18 PHARYNGEAL NEOPLASM 1 0.0064
19 DIASTASIS RECTI ABDOMINIS 1 0.0062
20 GALLBLADDER HYPOFUNCTION 1 0.0058
21 BILIARY CYST 1 0.0057
22 LARYNGEAL OBSTRUCTION 1 0.0055
23 ABNORMAL CLOTTING FACTOR 1 0.0049
24 LACTATION INSUFFICIENCY 1 0.0048
25 OESOPHAGEAL MASS 1 0.0048
26 PRODUCT ADMINISTRATION ISSUE 1 0.0048
27 MERALGIA PARAESTHETICA 1 0.0047
28 HISTAMINE LEVEL INCREASED 1 0.0046
29 MOYAMOYA DISEASE 1 0.0046
30 PRODUCT INTOLERANCE 1 0.0045
31 PUNCTURE SITE PAIN 1 0.0043
32 OESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 0.0041
33 VAGUS NERVE DISORDER 1 0.0040
34 TRACHEAL OBSTRUCTION 1 0.0038
35 SOLAR DERMATITIS 1 0.0037
36 ADMINISTRATION SITE PAIN 4 0.0035
37 LARYNGEAL STENOSIS 2 0.0035
38 PHYSICAL DECONDITIONING 8 0.0031
39 ADMINISTRATION SITE SWELLING 1 0.0031
40 TENOPLASTY 1 0.0029
41 STIFF PERSON SYNDROME 1 0.0029
42 DIAPHRAGMALGIA 1 0.0029
43 CIRCUMORAL OEDEMA 1 0.0029
44 EYE SYMPTOM 1 0.0028
45 IMMUNISATION REACTION 2 0.0028
46 BIPOLAR II DISORDER 1 0.0028
47 STRESS AT WORK 3 0.0027
48 PRODUCT ADMINISTERED BY WRONG PERSON 1 0.0026
49 DIVERTICULITIS INTESTINAL HAEMORRHAGIC 1 0.0026
50 HEMIPARAESTHESIA 1 0.0026
51 VULVAL OEDEMA 1 0.0025
52 MENINGEAL DISORDER 1 0.0025
53 ABDOMINAL SYMPTOM 2 0.0025
54 NAIL OPERATION 1 0.0024
55 MUSCLE STRENGTH ABNORMAL 1 0.0024
56 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
57 ENLARGED UVULA 1 0.0022
58 ALLERGY TO PLANTS 1 0.0022
59 NEEDLE FATIGUE 1 0.0022
60 EHLERS-DANLOS SYNDROME 1 0.0022
61 MASTOCYTOSIS 1 0.0021
62 FAECAL VOLUME DECREASED 1 0.0021
63 BRAIN NEOPLASM BENIGN 1 0.0020
64 FAECAL VOLUME INCREASED 1 0.0019
65 INADEQUATE DIET 1 0.0019
66 HYPERTENSIVE URGENCY 1 0.0018
67 EJACULATION DELAYED 1 0.0018
68 CORTISOL DECREASED 2 0.0017
69 VACCINATION SITE PAIN 1 0.0017
70 HYPOAESTHESIA EYE 1 0.0017
71 ANTEROGRADE AMNESIA 1 0.0017
72 PALATAL DISORDER 1 0.0017
73 LARYNGEAL DISCOMFORT 1 0.0016
74 ADJUSTMENT DISORDER 2 0.0015
75 HEAT ILLNESS 1 0.0015
76 LARYNGEAL OEDEMA 9 0.0015
77 CHRONIC FATIGUE SYNDROME 2 0.0014
78 MAST CELL ACTIVATION SYNDROME 2 0.0014
79 PELVIC FLUID COLLECTION 1 0.0014
80 MYOFASCIAL PAIN SYNDROME 1 0.0014
81 DENTAL RESTORATION FAILURE 1 0.0014
82 LIPIDS ABNORMAL 1 0.0014
83 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 1 0.0014
84 CLOSTRIDIUM TEST POSITIVE 3 0.0014
85 CATHETER SITE RELATED REACTION 1 0.0013
86 VEIN COLLAPSE 1 0.0013
87 MUSCLE DISCOMFORT 1 0.0013
88 PHARYNGEAL SWELLING 12 0.0012
89 POLYCYTHAEMIA VERA 1 0.0012
90 GASTROENTERITIS SALMONELLA 1 0.0012
91 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
92 MYCOTIC ALLERGY 1 0.0012
93 TONGUE MOVEMENT DISTURBANCE 1 0.0012
94 ATONIC SEIZURES 1 0.0012
95 FOOD REFUSAL 1 0.0011
96 GASTROINTESTINAL OEDEMA 2 0.0011
97 PRODUCT RECONSTITUTION QUALITY ISSUE 1 0.0011
98 VULVOVAGINAL SWELLING 2 0.0011
99 DEVICE RELATED THROMBOSIS 1 0.0010
100 BONE MARROW OEDEMA 1 0.0010
101 SINUSITIS BACTERIAL 1 0.0009
102 ALLERGY TO ANIMAL 1 0.0009
103 LYME DISEASE 3 0.0009
104 PAROTITIS 1 0.0009
105 INGROWING NAIL 2 0.0008
106 OTITIS EXTERNA 1 0.0008
107 TONGUE OEDEMA 3 0.0008
108 THERAPEUTIC PRODUCT INEFFECTIVE 3 0.0008
109 ABDOMINAL OPERATION 1 0.0008
110 FEELINGS OF WORTHLESSNESS 1 0.0008
111 CORONAVIRUS INFECTION 5 0.0008
112 LIP EXFOLIATION 1 0.0008
113 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
114 TONGUE DRY 1 0.0007
115 BILIARY TRACT DISORDER 1 0.0007
116 JOINT INSTABILITY 1 0.0007
117 LIP OEDEMA 3 0.0007
118 TRACHEOSTOMY 1 0.0007
119 PHARYNGEAL DISORDER 2 0.0007
120 NOROVIRUS INFECTION 1 0.0007
121 ACUTE ABDOMEN 1 0.0007
122 OROPHARYNGEAL DISCOMFORT 6 0.0007
123 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
124 INJECTION SITE PARAESTHESIA 1 0.0007
125 ORAL MUCOSAL ERUPTION 1 0.0007
126 CALCULUS URINARY 1 0.0006
127 INAPPROPRIATE AFFECT 1 0.0006
128 AORTIC VALVE DISEASE 1 0.0006
129 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
130 GASTRIC DILATATION 1 0.0006
131 EROSIVE OESOPHAGITIS 1 0.0006
132 INSURANCE ISSUE 9 0.0006
133 REGURGITATION 2 0.0006
134 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
135 FEAR OF DISEASE 1 0.0006
136 INDURATION 1 0.0006
137 GASTROINTESTINAL DISORDER 50 0.0006
138 NASAL OEDEMA 1 0.0006
139 BODY TEMPERATURE ABNORMAL 1 0.0005
140 PRODUCT DISTRIBUTION ISSUE 5 0.0005
141 INJECTION SITE CELLULITIS 1 0.0005
142 PERIORBITAL SWELLING 3 0.0005
143 LIP DISORDER 1 0.0005
144 HEPATIC MASS 1 0.0005
145 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
146 VOCAL CORD DISORDER 1 0.0005
147 EXPOSURE VIA BREAST MILK 2 0.0005
148 OBSTRUCTION 2 0.0005
149 EJACULATION FAILURE 1 0.0005
150 CORONARY ARTERY THROMBOSIS 1 0.0005
151 SUDDEN HEARING LOSS 1 0.0005
152 EAR HAEMORRHAGE 1 0.0005
153 EYELID PAIN 1 0.0005
154 ANAPHYLACTOID REACTION 2 0.0005
155 POOR VENOUS ACCESS 5 0.0005
156 WEIGHT FLUCTUATION 5 0.0005
157 DEVICE CONNECTION ISSUE 1 0.0005
158 SLEEP DEFICIT 1 0.0005
159 EAR SWELLING 1 0.0005
160 CATHETER SITE ERYTHEMA 1 0.0005
161 CARDIAC OPERATION 4 0.0005
162 GASTRIC CANCER STAGE IV 1 0.0005
163 URINE OUTPUT DECREASED 4 0.0005
164 BIPOLAR I DISORDER 1 0.0005
165 NOSOCOMIAL INFECTION 1 0.0005
166 FAECES PALE 1 0.0004
167 SPINAL COLUMN INJURY 1 0.0004
168 INFECTIOUS MONONUCLEOSIS 1 0.0004
169 PRODUCT USE COMPLAINT 7 0.0004
170 BRAIN OPERATION 1 0.0004
171 MENOPAUSAL SYMPTOMS 1 0.0004
172 DISCOURAGEMENT 1 0.0004
173 ORAL SURGERY 1 0.0004
174 ENDOMETRIOSIS 2 0.0004
175 GASTROINTESTINAL OBSTRUCTION 1 0.0004
176 VULVOVAGINAL PAIN 2 0.0004
177 RASH VESICULAR 2 0.0004
178 SLOW SPEECH 1 0.0004
179 EYELID IRRITATION 1 0.0004
180 OSTEITIS 1 0.0004
181 PRODUCT DOSE OMISSION IN ERROR 11 0.0004
182 CATHETER SITE PAIN 1 0.0004
183 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
184 MULTIPLE ALLERGIES 3 0.0004
185 JOINT DISLOCATION 4 0.0004
186 DYSMENORRHOEA 5 0.0004
187 FOOD POISONING 2 0.0004
188 ABDOMINAL MASS 1 0.0004
189 LIP BLISTER 1 0.0004
190 CHOKING SENSATION 2 0.0004
191 SWOLLEN TONGUE 11 0.0004
192 EYELID OEDEMA 4 0.0003
193 FACIAL PAIN 3 0.0003
194 ODYNOPHAGIA 2 0.0003
195 ATYPICAL PNEUMONIA 1 0.0003
196 CEREBROVASCULAR DISORDER 1 0.0003
197 DIABETIC FOOT 1 0.0003
198 MENISCUS INJURY 2 0.0003
199 ECTOPIC PREGNANCY 1 0.0003
200 INFUSION SITE EXTRAVASATION 2 0.0003
201 DIARRHOEA HAEMORRHAGIC 3 0.0003
202 SWELLING OF EYELID 2 0.0003
203 BRAIN OEDEMA 4 0.0003
204 INJECTION SITE INDURATION 4 0.0003
205 LIVER ABSCESS 1 0.0003
206 THERAPY CHANGE 3 0.0003
207 NEPHRITIS 1 0.0003
208 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
209 HEPATIC CYST 1 0.0003
210 B-CELL LYMPHOMA 1 0.0003
211 EAR DISCOMFORT 3 0.0003
212 CERVICAL VERTEBRAL FRACTURE 1 0.0003
213 HYPOPNOEA 1 0.0003
214 DYSPEPSIA 28 0.0003
215 TYPE I HYPERSENSITIVITY 1 0.0003
216 HEART DISEASE CONGENITAL 1 0.0003
217 SEASONAL ALLERGY 4 0.0003
218 APPENDICECTOMY 1 0.0003
219 PHARYNGITIS STREPTOCOCCAL 3 0.0003
220 INTENTIONAL UNDERDOSE 2 0.0003
221 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
222 ARTHROPOD BITE 2 0.0003
223 ABDOMINAL DISTENSION 28 0.0003
224 AUTOIMMUNE THYROIDITIS 1 0.0003
225 OESOPHAGEAL ULCER 1 0.0003
226 PHARYNGEAL OEDEMA 4 0.0003
227 DEVICE RELATED INFECTION 4 0.0003
228 OESOPHAGEAL DISORDER 1 0.0003
229 FOOD ALLERGY 2 0.0003
230 EPIGASTRIC DISCOMFORT 1 0.0003
231 ORAL INFECTION 1 0.0003
232 OESOPHAGEAL PAIN 1 0.0003
233 SKIN PAPILLOMA 1 0.0002
234 INTRACRANIAL ANEURYSM 1 0.0002
235 VITAMIN B12 DEFICIENCY 1 0.0002
236 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
237 TRIGGER FINGER 1 0.0002
238 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
239 INJECTION SITE IRRITATION 3 0.0002
240 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
241 TENSION HEADACHE 1 0.0002
242 HORDEOLUM 1 0.0002
243 SWELLING FACE 15 0.0002
244 SYRINGE ISSUE 4 0.0002
245 MELANOCYTIC NAEVUS 1 0.0002
246 GROIN PAIN 2 0.0002
247 LIGAMENT RUPTURE 1 0.0002
248 RHINITIS ALLERGIC 1 0.0002
249 ABDOMINAL PAIN 52 0.0002
250 GASTROINTESTINAL INFECTION 2 0.0002
251 THROAT TIGHTNESS 6 0.0002
252 GASTROENTERITIS VIRAL 4 0.0002
253 PAPILLOEDEMA 1 0.0002
254 SUSPECTED OFF LABEL USE 1 0.0002
255 PRODUCT AVAILABILITY ISSUE 5 0.0002
256 ABDOMINAL HERNIA 1 0.0002
257 BRAIN NEOPLASM 2 0.0002
258 LOCALISED OEDEMA 1 0.0002
259 GASTRITIS EROSIVE 1 0.0002
260 PERFORMANCE STATUS DECREASED 1 0.0002
261 UMBILICAL HERNIA 1 0.0002
262 TIBIA FRACTURE 1 0.0002
263 SKIN TIGHTNESS 1 0.0002
264 SKIN ABRASION 1 0.0002
265 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
266 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
267 ERUCTATION 4 0.0002
268 EAR PAIN 4 0.0002
269 COVID-19 36 0.0002
270 INCORRECT DOSAGE ADMINISTERED 1 0.0002
271 INJECTION SITE URTICARIA 5 0.0002
272 LIGAMENT SPRAIN 2 0.0002
273 FOOT OPERATION 1 0.0002
274 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
275 ABDOMINAL TENDERNESS 1 0.0002
276 ANEURYSM 1 0.0002
277 FLUID INTAKE REDUCED 1 0.0002
278 VEIN DISORDER 1 0.0002
279 DYSPHORIA 1 0.0002
280 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
281 TONSILLITIS 1 0.0002
282 MALABSORPTION 1 0.0002
283 INJECTION SITE DISCOMFORT 2 0.0002
284 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
285 EAR INFECTION 5 0.0002
286 JOINT INJURY 4 0.0002
287 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
288 OVERWEIGHT 1 0.0002
289 INJECTION SITE DISCHARGE 1 0.0002
290 PRODUCT RESIDUE PRESENT 1 0.0002
291 FREQUENT BOWEL MOVEMENTS 5 0.0002
292 ILLNESS 19 0.0002
293 BIPOLAR DISORDER 2 0.0002
294 BACK INJURY 2 0.0002
295 PRODUCT PRESCRIBING ISSUE 4 0.0002
296 HYDROCEPHALUS 1 0.0002
297 TIC 1 0.0002
298 NONSPECIFIC REACTION 1 0.0002
299 AUTISM SPECTRUM DISORDER 1 0.0002
300 DEAFNESS UNILATERAL 1 0.0002
301 DENTAL CARIES 2 0.0002
302 EXPIRED PRODUCT ADMINISTERED 6 0.0002
303 LIP SWELLING 6 0.0002
304 TOOTH DISORDER 4 0.0002
305 STREPTOCOCCAL INFECTION 1 0.0002
306 INTRACRANIAL PRESSURE INCREASED 1 0.0002
307 INTERMENSTRUAL BLEEDING 1 0.0002
308 FACE OEDEMA 3 0.0002
309 EYE INFECTION 2 0.0002
310 ABDOMINAL PAIN UPPER 36 0.0002
311 MUSCULOSKELETAL DISCOMFORT 3 0.0002
312 NEOPLASM 2 0.0002
313 ENTEROCOLITIS 1 0.0002
314 HYPERVENTILATION 1 0.0002
315 AMENORRHOEA 3 0.0002
316 HYPOVOLAEMIA 1 0.0002
317 SPINAL PAIN 2 0.0002
318 HYPERCHLORHYDRIA 1 0.0002
319 ENERGY INCREASED 1 0.0002
320 PLEURISY 1 0.0002
321 INJECTION SITE VESICLES 1 0.0002
322 ADRENAL INSUFFICIENCY 2 0.0002
323 TENSION 1 0.0002
324 GENERALISED OEDEMA 2 0.0002
325 NASAL DRYNESS 1 0.0002
326 FOOT FRACTURE 3 0.0002
327 GASTRIC ULCER 3 0.0002
328 SLEEP APNOEA SYNDROME 3 0.0002
329 CYSTITIS 5 0.0002
330 INFUSION SITE PAIN 2 0.0002
331 CONDITION AGGRAVATED 47 0.0002
332 POLYP 1 0.0002
333 BLOOD PRESSURE ABNORMAL 3 0.0002
334 VIRAL INFECTION 5 0.0002
335 PREGNANCY 3 0.0001
336 SKIN MASS 1 0.0001
337 POST-TRAUMATIC STRESS DISORDER 1 0.0001
338 BREAST MASS 1 0.0001
339 TASTE DISORDER 3 0.0001
340 LIMB INJURY 4 0.0001
341 MATERNAL EXPOSURE DURING PREGNANCY 13 0.0001
342 ONYCHOCLASIS 1 0.0001
343 LARGE INTESTINE POLYP 1 0.0001
344 FORMICATION 1 0.0001
345 EXTRASYSTOLES 1 0.0001
346 CARPAL TUNNEL SYNDROME 2 0.0001
347 PAPULE 1 0.0001
348 DUODENAL ULCER 1 0.0001
349 FLATULENCE 8 0.0001
350 THERMAL BURN 1 0.0001
351 INTENTIONAL DOSE OMISSION 4 0.0001
352 IMPAIRED QUALITY OF LIFE 2 0.0001
353 PANIC REACTION 1 0.0001
354 VISUAL FIELD DEFECT 1 0.0001
355 TONGUE DISORDER 1 0.0001
356 FAECES SOFT 1 0.0001
357 ANGIOEDEMA 6 0.0001
358 SENSITIVE SKIN 1 0.0001
359 PULMONARY MASS 2 0.0001
360 THROAT IRRITATION 6 0.0001
361 BREAST TENDERNESS 1 0.0001
362 BOWEL MOVEMENT IRREGULARITY 1 0.0001
363 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
364 INJECTION SITE SWELLING 10 0.0001
365 INJECTION SITE RASH 4 0.0001
366 PERIPHERAL SWELLING 20 0.0001
367 LYMPHOMA 2 0.0001
368 APHTHOUS ULCER 1 0.0001
369 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
370 SWELLING 12 0.0001
371 PRODUCT USE ISSUE 24 0.0001
372 GASTROINTESTINAL INFLAMMATION 1 0.0001
373 BRAIN FOG 2 0.0001
374 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
375 AFFECTIVE DISORDER 1 0.0001
376 NASAL DISCOMFORT 1 0.0001
377 PNEUMOTHORAX 2 0.0001
378 ABSCESS 2 0.0001
379 INJECTION SITE BRUISING 10 0.0001
380 MOVEMENT DISORDER 4 0.0001
381 OXYGEN SATURATION DECREASED 7 0.0001
382 RHINITIS 1 0.0001
383 FRUSTRATION TOLERANCE DECREASED 1 0.0001
384 ABNORMAL FAECES 1 0.0001
385 HICCUPS 1 0.0001
386 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
387 URINARY RETENTION 4 0.0001
388 DYSPHONIA 7 0.0001
389 PALPITATIONS 14 0.0001
390 INFUSION SITE ERYTHEMA 1 0.0001
391 HAEMATEMESIS 3 0.0001
392 FACIAL PARALYSIS 1 0.0001
393 ERECTILE DYSFUNCTION 3 0.0001
394 RECTAL HAEMORRHAGE 5 0.0001
395 ANURIA 1 0.0001
396 MUSCLE STRAIN 1 0.0001
397 CARDIAC MURMUR 1 0.0001
398 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
399 SPINAL OSTEOARTHRITIS 1 0.0001
400 ABDOMINAL DISCOMFORT 19 0.0001
401 HEAD DISCOMFORT 2 0.0001
402 RESPIRATORY RATE INCREASED 1 0.0001
403 ANAL INCONTINENCE 1 0.0001
404 HEAVY MENSTRUAL BLEEDING 1 0.0001
405 TOOTHACHE 2 0.0001
406 PALLOR 3 0.0001
407 LIP DRY 1 0.0001
408 RESTLESS LEGS SYNDROME 2 0.0001
409 PNEUMONIA BACTERIAL 1 0.0001
410 INCREASED TENDENCY TO BRUISE 1 0.0001
411 DIVERTICULITIS 3 0.0001
412 PERSONALITY CHANGE 1 0.0001
413 BACK PAIN 25 0.0001
414 INFLUENZA 12 0.0001
415 HEPATIC CIRRHOSIS 2 0.0001
416 LEUKAEMIA 1 0.0001
417 PRODUCT DOSE OMISSION ISSUE 31 0.0001
418 HYPERSOMNIA 3 0.0001
419 INJECTION SITE PRURITUS 7 0.0001
420 POST PROCEDURAL COMPLICATION 2 0.0001
421 HERNIA 2 0.0001
422 NEEDLE ISSUE 3 0.0001
423 DYSSTASIA 3 0.0001
424 BONE PAIN 6 0.0001
425 INFLAMMATORY BOWEL DISEASE 1 0.0001
426 COELIAC DISEASE 1 0.0001
427 KNEE OPERATION 1 0.0001
428 URTICARIA 17 0.0001
429 INJECTION SITE PAIN 31 0.0001
430 BLADDER DISORDER 1 0.0001
431 INABILITY TO AFFORD MEDICATION 1 0.0001
432 UPPER LIMB FRACTURE 2 0.0001
433 ABORTION SPONTANEOUS 4 0.0001
434 DRUG LEVEL DECREASED 1 0.0001
435 TOOTH ABSCESS 1 0.0001
436 MOTOR DYSFUNCTION 1 0.0001
437 SLUGGISHNESS 1 0.0001
438 NASOPHARYNGITIS 18 0.0001
439 HELICOBACTER INFECTION 1 0.0001
440 TEMPERATURE INTOLERANCE 1 0.0001
441 EYE DISCHARGE 1 0.0001
442 DIARRHOEA 62 0.0001
443 TENDERNESS 1 0.0001
444 ROAD TRAFFIC ACCIDENT 4 0.0001
445 INCONTINENCE 1 0.0001
446 IRRITABLE BOWEL SYNDROME 2 0.0001
447 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
448 CHOLELITHIASIS 3 0.0001
449 INJECTION SITE NODULE 1 0.0001
450 TOOTH FRACTURE 1 0.0001
451 HAEMATOCHEZIA 5 0.0001
452 DEHYDRATION 12 0.0001
453 NERVE INJURY 1 0.0001
454 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
455 HYPERTENSIVE CRISIS 1 0.0001
456 MALNUTRITION 1 0.0001
457 HEADACHE 56 0.0001
458 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
459 OCULAR DISCOMFORT 1 0.0001
460 PANCREATITIS ACUTE 2 0.0001
461 FISTULA 1 0.0001
462 INJECTION SITE ERYTHEMA 11 0.0001
463 DRUG INTERACTION 14 0.0001
464 GASTRIC DISORDER 3 0.0001
465 NEPHROLITHIASIS 4 0.0001
466 INJECTION SITE REACTION 6 0.0001
467 SPLENOMEGALY 1 0.0001
468 VOMITING 40 0.0001
469 COVID-19 PNEUMONIA 1 0.0001
470 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
471 ARRHYTHMIA 4 0.0001
472 MALAISE 37 0.0001
473 MIGRAINE 8 0.0001
474 ACCIDENT 1 0.0001
475 MACULAR DEGENERATION 1 0.0001
476 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
477 THYROID CANCER 1 0.0001
478 MENTAL IMPAIRMENT 2 0.0001
479 FIBROMYALGIA 2 0.0001
480 PRESYNCOPE 2 0.0001
481 NEURALGIA 2 0.0001
482 DISCOMFORT 5 0.0001
483 DYSURIA 3 0.0001
484 SMALL INTESTINAL OBSTRUCTION 1 0.0001
485 BRONCHITIS 6 0.0001
486 INJECTION SITE DISCOLOURATION 1 0.0001
487 NAUSEA 63 0.0001
488 INTESTINAL OBSTRUCTION 3 0.0001
489 COLITIS 3 0.0001
490 FLUID RETENTION 4 0.0001
491 HEPATIC CYTOLYSIS 1 0.0001
492 INTRAOCULAR PRESSURE INCREASED 1 0.0001
493 MYDRIASIS 1 0.0001
494 THERAPY CESSATION 4 0.0001
495 HIATUS HERNIA 1 0.0001
496 NODULE 1 0.0001
497 DEAFNESS 2 0.0001
498 GASTRITIS 2 0.0001
499 IMMUNE SYSTEM DISORDER 1 0.0001
500 SARS-COV-2 TEST POSITIVE 1 0.0001
501 PANCREATITIS 4 0.0001
502 THROMBOSIS 6 0.0001
503 RASH PRURITIC 4 0.0001
504 OEDEMA 4 0.0001
505 DYSPHAGIA 7 0.0001
506 TREATMENT NONCOMPLIANCE 4 0.0001
507 RESPIRATORY DISTRESS 2 0.0001
508 ORAL DISCOMFORT 1 0.0001
509 FEELING COLD 2 0.0001
510 WEIGHT DECREASED 20 0.0001
511 MASS 1 0.0001
512 WEIGHT INCREASED 16 0.0001
513 BLOOD TEST ABNORMAL 1 0.0001
514 PAIN IN JAW 2 0.0001
515 LOSS OF CONSCIOUSNESS 9 0.0001
516 ACCIDENTAL UNDERDOSE 1 0.0001
517 PARAESTHESIA ORAL 1 0.0001
518 FALL 23 0.0001
519 RESPIRATORY FAILURE 5 0.0001
520 GASTROENTERITIS 1 0.0001
521 MUSCULOSKELETAL STIFFNESS 6 0.0001
522 CARDIOMYOPATHY 1 0.0001
523 LIVER DISORDER 3 0.0001
524 RESPIRATORY DISORDER 2 0.0001
525 THERAPY NON-RESPONDER 3 0.0001
526 ECONOMIC PROBLEM 1 0.0001
527 ILL-DEFINED DISORDER 4 0.0001
528 TINNITUS 3 0.0001
529 SKIN DISCOLOURATION 3 0.0001
530 THYROID DISORDER 1 0.0001
531 LIMB DISCOMFORT 2 0.0001
532 MUSCULOSKELETAL CHEST PAIN 1 0.0001
533 SOMNOLENCE 13 0.0001
534 DIZZINESS 32 0.0001
535 MENINGIOMA 1 0.0001
536 SICKLE CELL ANAEMIA WITH CRISIS 1 0.0001
537 COMA 3 0.0001
538 ULCER 1 0.0001
539 SCIATICA 1 0.0001
540 CONTUSION 6 0.0001
541 BLOOD POTASSIUM INCREASED 1 0.0001
542 DEEP VEIN THROMBOSIS 4 0.0001
543 BACK DISORDER 1 0.0001
544 PHOTOSENSITIVITY REACTION 1 0.0001
545 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
546 INFUSION RELATED REACTION 4 0.0001
547 NEOPLASM MALIGNANT 4 0.0001
548 PRURITUS 23 0.0001
549 CONSTIPATION 13 0.0001
550 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
551 CHEST PAIN 11 0.0001
552 ANGER 2 0.0001
553 CEREBROVASCULAR ACCIDENT 10 0.0001
554 BLOOD PRESSURE INCREASED 9 0.0001
555 RASH MACULAR 2 0.0001
556 INTENTIONAL PRODUCT MISUSE 5 0.0001
557 HEART RATE DECREASED 2 0.0001
558 DEPRESSED MOOD 3 0.0001
559 COLD SWEAT 1 0.0001
560 SLEEP DISORDER 4 0.0001
561 FATIGUE 44 0.0001
562 LYMPHADENOPATHY 2 0.0001
563 GALLBLADDER DISORDER 1 0.0001
564 THERAPY INTERRUPTED 4 0.0001
565 CEREBRAL HAEMORRHAGE 2 0.0001
566 LEUKOCYTOSIS 1 0.0001
567 OSTEOMYELITIS 1 0.0001
568 PANIC ATTACK 2 0.0001
569 INJECTION SITE MASS 2 0.0001
570 OROPHARYNGEAL PAIN 5 0.0001
571 ARTHROPATHY 3 0.0001
572 CONJUNCTIVITIS 1 0.0001
573 EYE SWELLING 2 0.0001
574 HYPOAESTHESIA 8 0.0001
575 PHOTOPHOBIA 1 0.0001
576 ACNE 4 0.0001
577 PROTEINURIA 1 0.0001
578 INCREASED APPETITE 1 0.0001
579 SEIZURE 6 0.0001
580 ATRIAL FIBRILLATION 5 0.0001
581 ARTHRITIS 4 0.0001
582 SINUS DISORDER 1 0.0001
583 DISORIENTATION 2 0.0001
584 CATARACT 3 0.0001
585 INJECTION SITE HAEMORRHAGE 4 0.0001
586 SYNCOPE 5 0.0000
587 PRODUCT ADMINISTRATION ERROR 1 0.0000
588 STOMATITIS 3 0.0000
589 FEEDING DISORDER 1 0.0000
590 VERTIGO 3 0.0000
591 ANXIETY 14 0.0000
592 BODY TEMPERATURE INCREASED 1 0.0000
593 LUNG NEOPLASM MALIGNANT 2 0.0000
594 INJECTION SITE WARMTH 1 0.0000
595 RIB FRACTURE 1 0.0000
596 INFLUENZA LIKE ILLNESS 4 0.0000
597 HYPERSENSITIVITY 9 0.0000
598 PULMONARY HYPERTENSION 1 0.0000
599 POLLAKIURIA 2 0.0000
600 PAIN 29 0.0000
601 RETCHING 1 0.0000
602 SKIN CANCER 1 0.0000
603 PNEUMONIA 15 0.0000
604 DRUG INEFFECTIVE 61 0.0000
605 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
606 FAECES DISCOLOURED 1 0.0000
607 MENTAL DISORDER 2 0.0000
608 FEELING ABNORMAL 11 0.0000
609 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
610 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
611 BLOOD PRESSURE DECREASED 3 0.0000
612 GLOSSODYNIA 1 0.0000
613 RASH PAPULAR 1 0.0000
614 SNEEZING 1 0.0000
615 ADVERSE DRUG REACTION 4 0.0000
616 PARAESTHESIA 7 0.0000
617 HEART RATE IRREGULAR 1 0.0000
618 HEPATIC ENZYME INCREASED 3 0.0000
619 SHOCK 1 0.0000
620 ARTHRALGIA 18 0.0000
621 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
622 BLOOD CHOLESTEROL INCREASED 2 0.0000
623 BURNING SENSATION 3 0.0000
624 CARDIAC DISORDER 4 0.0000
625 INJURY 3 0.0000
626 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
627 GAIT DISTURBANCE 8 0.0000
628 BLOOD PRESSURE FLUCTUATION 1 0.0000
629 LOCALISED INFECTION 1 0.0000
630 INSOMNIA 11 0.0000
631 OEDEMA PERIPHERAL 5 0.0000
632 CELLULITIS 2 0.0000
633 CHEST DISCOMFORT 4 0.0000
634 SINUSITIS 4 0.0000
635 HAEMATOMA 1 0.0000
636 NERVOUSNESS 2 0.0000
637 MUSCULOSKELETAL PAIN 2 0.0000
638 BRADYCARDIA 2 0.0000
639 CARDIAC FAILURE CONGESTIVE 3 0.0000
640 FEAR 1 0.0000
641 RASH 16 0.0000
642 MOOD ALTERED 1 0.0000
643 VISION BLURRED 5 0.0000
644 CARDIAC ARREST 3 0.0000
645 PROCEDURAL PAIN 1 0.0000
646 HAEMOPTYSIS 1 0.0000
647 RENAL IMPAIRMENT 3 0.0000
648 EYE PAIN 2 0.0000
649 DYSPNOEA 20 0.0000
650 DEPRESSION 8 0.0000
651 BALANCE DISORDER 3 0.0000
652 INFECTION 5 0.0000
653 DECREASED APPETITE 8 0.0000
654 PRODUCT STORAGE ERROR 3 0.0000
655 SURGERY 2 0.0000
656 ERYTHEMA 7 0.0000
657 LABORATORY TEST ABNORMAL 1 0.0000
658 TACHYCARDIA 3 0.0000
659 URINARY INCONTINENCE 1 0.0000
660 DEVICE ISSUE 3 0.0000
661 IRRITABILITY 2 0.0000
662 BLOOD POTASSIUM DECREASED 1 0.0000
663 PREMATURE BABY 1 0.0000
664 HEPATIC FAILURE 1 0.0000
665 NO ADVERSE EVENT 6 0.0000
666 LACRIMATION INCREASED 1 0.0000
667 THERAPEUTIC RESPONSE DECREASED 2 0.0000
668 PLEURAL EFFUSION 2 0.0000
669 FEELING HOT 2 0.0000
670 ADVERSE EVENT 3 0.0000
671 EMOTIONAL DISORDER 1 0.0000
672 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
673 EXPOSURE DURING PREGNANCY 2 0.0000
674 COUGH 9 0.0000
675 OFF LABEL USE 28 0.0000
676 PYREXIA 11 0.0000
677 MOOD SWINGS 1 0.0000
678 NIGHT SWEATS 1 0.0000
679 IMPAIRED HEALING 1 0.0000
680 STAPHYLOCOCCAL INFECTION 1 0.0000
681 HEART RATE INCREASED 3 0.0000
682 TREMOR 5 0.0000
683 VISUAL ACUITY REDUCED 1 0.0000
684 SKIN DISORDER 1 0.0000
685 GAIT INABILITY 1 0.0000
686 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
687 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
688 MYALGIA 5 0.0000
689 NIGHTMARE 1 0.0000
690 HAEMORRHAGE 3 0.0000
691 ACCIDENTAL OVERDOSE 1 0.0000
692 HEPATIC FUNCTION ABNORMAL 1 0.0000
693 ASTHENIA 10 0.0000
694 ASTHMA 3 0.0000
695 CHRONIC KIDNEY DISEASE 2 0.0000
696 HOSPITALISATION 4 0.0000
697 CHILLS 3 0.0000
698 JOINT SWELLING 3 0.0000
699 EXTRA DOSE ADMINISTERED 1 0.0000
700 PSORIATIC ARTHROPATHY 1 0.0000
701 DYSKINESIA 1 0.0000
702 SKIN EXFOLIATION 2 0.0000
703 DEATH 20 0.0000
704 COLITIS ULCERATIVE 1 0.0000
705 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
706 INCORRECT DOSE ADMINISTERED 5 0.0000
707 SUICIDAL IDEATION 2 0.0000
708 MEMORY IMPAIRMENT 3 0.0000
709 MUSCLE SPASMS 4 0.0000
710 RENAL DISORDER 1 0.0000
711 PULMONARY EMBOLISM 2 0.0000
712 RASH ERYTHEMATOUS 1 0.0000
713 DRUG INTOLERANCE 2 0.0000
714 HYPOGLYCAEMIA 1 0.0000
715 LUNG DISORDER 1 0.0000
716 PAIN IN EXTREMITY 6 0.0000
717 DRY EYE 1 0.0000
718 AGGRESSION 1 0.0000
719 HYPOTENSION 4 0.0000
720 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
721 INFLAMMATION 1 0.0000
722 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
723 ECZEMA 1 0.0000
724 SPEECH DISORDER 1 0.0000
725 DISTURBANCE IN ATTENTION 1 0.0000
726 NECK PAIN 1 0.0000
727 BLISTER 1 0.0000
728 MUSCULAR WEAKNESS 2 0.0000
729 URINARY TRACT INFECTION 3 0.0000
730 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
731 WHEEZING 1 0.0000
732 VISUAL IMPAIRMENT 2 0.0000
733 HYPERHIDROSIS 2 0.0000
734 AMNESIA 1 0.0000
735 RENAL FAILURE 2 0.0000
736 HYPERTENSION 3 0.0000
737 SKIN BURNING SENSATION 1 0.0000
738 OVERDOSE 3 0.0000
739 UNDERDOSE 1 0.0000
740 AGITATION 1 0.0000
741 DYSGEUSIA 1 0.0000
742 EPISTAXIS 1 0.0000
743 UNEVALUABLE EVENT 1 0.0000
744 DIABETES MELLITUS 1 0.0000
745 CARDIAC FAILURE 1 0.0000
746 DRY MOUTH 1 0.0000
747 COMPLETED SUICIDE 1 0.0000
748 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
749 BREAST CANCER 1 0.0000
750 NEUROPATHY PERIPHERAL 1 0.0000
751 ALOPECIA 2 0.0000
752 HAEMOGLOBIN DECREASED 1 0.0000
753 DISEASE PROGRESSION 1 0.0000
754 EMOTIONAL DISTRESS 1 0.0000
755 DRY SKIN 1 0.0000
756 CONFUSIONAL STATE 1 0.0000
757 MYOCARDIAL INFARCTION 1 0.0000